Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 23, 2011
HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells
Karuppiah Muthumani, Devon J Shedlock, Daniel K Choo, et al.
Vaccine
|
January 18, 2011
A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge
Devon J Shedlock, Kendra T Talbott, Christina Cress, et al.
Plos Medicine
|
May 11, 2006
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J Sullivan, Thomas W Geisbert, Joan B Geisbert, et al.
Molecular Pharmaceutics
|
November 4, 2014
A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
Jin Huk Choi, Kristina Jonsson-Schmunk, Xiangguo Qiu, et al.
Plos Neglected Tropical Diseases
|
January 26, 2011
A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates
Karthik Mallilankaraman, Devon J Shedlock, Huihui Bao, et al.
Plos One
|
June 25, 2011
Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine
Sarah E Belisle, Jiangmei Yin, Devon J Shedlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2026
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Susan Slovin, Xin Gao, Xiao X Wei, et al.
Nature Communications
|
November 24, 2025
T<sub>SCM</sub>-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial
Hubert Tseng, Bhagirathbhai Dholaria, Stacey A Cranert, et al.
The Journal of Infectious Diseases
|
October 11, 2018
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines
Ami Patel, Emma L Reuschel, Kimberly A Kraynyak, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 23, 2011
HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells
Karuppiah Muthumani, Devon J Shedlock, Daniel K Choo, et al.
Vaccine
|
January 18, 2011
A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge
Devon J Shedlock, Kendra T Talbott, Christina Cress, et al.
Plos Medicine
|
May 11, 2006
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J Sullivan, Thomas W Geisbert, Joan B Geisbert, et al.
Molecular Pharmaceutics
|
November 4, 2014
A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
Jin Huk Choi, Kristina Jonsson-Schmunk, Xiangguo Qiu, et al.
Plos Neglected Tropical Diseases
|
January 26, 2011
A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates
Karthik Mallilankaraman, Devon J Shedlock, Huihui Bao, et al.
Plos One
|
June 25, 2011
Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine
Sarah E Belisle, Jiangmei Yin, Devon J Shedlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2026
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Susan Slovin, Xin Gao, Xiao X Wei, et al.
Nature Communications
|
November 24, 2025
T<sub>SCM</sub>-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial
Hubert Tseng, Bhagirathbhai Dholaria, Stacey A Cranert, et al.
The Journal of Infectious Diseases
|
October 11, 2018
Protective Efficacy and Long-Term Immunogenicity in Cynomolgus Macaques by Ebola Virus Glycoprotein Synthetic DNA Vaccines
Ami Patel, Emma L Reuschel, Kimberly A Kraynyak, et al.
Page
of 4